You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Galcanezumab

Showing 26 - 35 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Dallas (Galcanezumab, Placebo)

Completed
Has Results
  • Healthy
  • Galcanezumab
  • Placebo
  • Dallas, Texas
    Covance
Oct 19, 2018

MIDAS Reduction at 3 Months for Erenumab Treatment

Completed
  • Migraine
  • Erenumab 70/140 mg s.c.
  • Pavia, Italy
    Headache Science & Neurorehabilitation Center
Jun 28, 2022

Migraine Trial in Worldwide (Galcanezumab, Placebo)

Completed
Has Results
  • Migraine
  • Galcanezumab
  • Placebo
  • Phoenix, Arizona
  • +112 more
Jun 10, 2020

Migraine Using Enerumab and Traditional Therapy at Time of

Completed
  • Migraine Disorders
  • Fayoum, Egypt
    Marwa Kamal Ahmed Tolba
Sep 17, 2021

Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)

Recruiting
  • Migraine
  • Head Pain
    • Valladolid, Spain
      Hospital Clínico Universitario de Valladolid
    Mar 23, 2023

    Episodic Cluster Headache Trial in Worldwide (Galcanezumab, Placebo)

    Completed
    Has Results
    • Episodic Cluster Headache
    • Galcanezumab
    • Placebo
    • Los Angeles, California
    • +46 more
    Aug 26, 2019

    Migraine Headache Trial in United States (Galcanezumab, Placebo)

    Completed
    Has Results
    • Migraine Headache
    • Galcanezumab
    • Placebo
    • Gilbert, Arizona
    • +39 more
    Nov 20, 2018

    BIOmarkers of MIGraine:Proof of Concept Study Based on

    Recruiting
    • Migraine
      • Hamburg, Germany
      • +2 more
      Apr 27, 2021

      Migraine Disorders Trial in United States (Capsaicin)

      Completed
      Has Results
      • Migraine Disorders
      • Phoenix, Arizona
      • +13 more
      Mar 29, 2019

      Chronic Migraine, Headache, Overuse Headache Medication Trial (Placebo oral drops, Cannabidiol + Cannabigerol +

      Not yet recruiting
      • Chronic Migraine, Headache
      • Overuse Headache Medication
      • Placebo oral drops
      • Cannabidiol + Cannabigerol + Tetrahydrocannabinol 133/66/4mg
      • (no location specified)
      Aug 3, 2021